Aggarwal C,Bubendorf L,Cooper WA,Illei P,Borralho Nunes P,Ong BH,Tsao MS,Yatabe Y,Kerr KM Y .2021 .Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges. Lung Cancer, 162 : 42-53.
Medica Associazione .2021 .Ethical principles for medical research involving human subjects]. Assist. Inferm Ric, 20(2) : 104-107.
Cheng S,Pei R,Li J,Li B,Tang L,Yin T,Liu S T .2021 .Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: A cost-effectiveness analysis from US and Chinese perspectives. Ann. Transl. Med, 9(18) : 1481.
Divisi D,De Vico A,Zaccagna G,Irelli A,Aielli F,Cannita K,Martella F K .2021 .NSCLC immunotherapy and related rare toxicities: a monocentric real-life experience. Cancer Med, 4(3) : 115-119.
Evers J,Hendriks LEL,De Jaeger K,Wijsman R,De Ruysscher D,Terhaard C,van der Sangen M,Siesling S,Struikmans H,Aarts MJ H .2021 .Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide populationbased study from the Netherlands. Lung Cancer, 162 : 61-70.
Fang C,Liu T,Liang W,Feng S,Su Z,Tang H,Huang H,Chen Z H .2021 .Clinical pharmacist participation in selecting and dosing targeted drugs for a patient with ALK-positive non-small cell lung cancer: A case report. Ann Transl Med, 9(18) : 1488.
Hill H,Robinson M,Lu L,Slaughter D,Amin A,Mileham K,Patel JN K .2021 .Venous thromboembolism incidence and risk factors in nonsmall cell lung cancer patients receiving first-line systemic therapy. Thromb. Res., 208 : 71-78.
Hockenhull K,Ortega-Franco A,Califano R .2021 .Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: The new kid on the block. Transl Lung Cancer Res, 10(9) : 3850-3854.
Jain P,Khorrami M,Gupta A,Rajiah P,Bera K,Viswanathan VS,Fu P,Dowlati A,Madabhushi A .2021 .Novel non-invasive radiomic signature on ct scans predicts response to platinum-based chemotherapy and is prognostic of overall survival in small cell lung cancer. Front Oncol., 11 : 744724.
Kepp O Kroemer G .2021 .Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade. , 10(1) : 1996686.
Kunimasa K,Okami J,Takenaka S,Honma K,Kukita Y,Nagata S,Kawamura T,Inoue T,Tamiya M,Kuhara H,Nishino K,Tahara H,Kumagai T H .2021 .Conversion surgery for advanced thoracic SMARCA4- deficient undifferentiated tumor with atezolizumab in combination with bevacizumab, paclitaxel, and carboplatin treatment: A case report. JTO Clin. Res. Rep, 2(11) : 100235.
Li D,Wang Y,Li C,Wang Q,Sun B,Zhang H,He Z,Sun J .2021 .Cancer-speci fi c calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced antimetastasis combinational chemotherapy. Acta Pharm Sin. B., 11(10) : 3262-3271.
Murat-Ringot A,Souquet PJ,Subtil F,Boutitie F,Preau M,Piriou V .2021 .The effect of foot reflexology on chemotherapy-induced nausea and vomiting in patients with digestive or lung cancer: Randomized controlled trial. JMIR Cancer, 7(4) : e25648.
Okamoto M,Kim YH,Ouchi A,Yamaoka T,Iwamoto N,Iwatsubo S,Matsumura K,Nakamura M,Kin Y,Shiina Y,Funada Y Y .2021 .Exacerbation of nontuberculous mycobacterial pulmonary disease in a patient with advanced non-small-cell lung cancer during treatment with PD-1 inhibitor and chemotherapy. Respir. Med. Case Rep, 34 : 101529.
Pan P,Wu F,Xu Z,Ji X,Qi Q,Huang X,Zhao R,Liu M,Jiang P,Li Y,Xu L Y .2021 .Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world. Thorac Cancer, 12(24) : 3416-3425.
Pujol JL,Vansteenkiste J,Paz-Ares Rodriguez L,Gregorc V,Mazieres J,Awad M,Jänne PA,Chisamore M,Hossain AM,Chen Y,Beck JT Y .2021 .Abemaciclib in combination with pembrolizumab for stage IV KRAS-mutant or squamous NSCLC: A phase 1b study. JTO Clin. Res. Rep, 2(11) : 100234.
Sasaki T,Tabata T,Yoshimura N .2021 .For which lung cancer patients is re-administration of immune checkpoint inhibitors effective. J. Rural Med, 16(4) : 256-262.
Saw SPL,Ong BH,Chua KLM,Takano A,Tan DSW .2021 .Revisiting neoadjuvant therapy in non-smallcell lung cancer. Lancet Oncol., 22(11) : e501-e516.
Subramaniyan V,Fuloria S,Gupta G,Kumar DH,Sekar M,Sathasivam KV,Sudhakar K,Alharbi KS,Al-Malki WH,Afzal O,Kazmi I,Al-Abbasi FA,Altamimi ASA,Fuloria NK .2021 .A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer. Chem. Biol. Interact, 351 : 109735.
Terao T,Kumagi T,Hyodo I,Yokota T,Azemoto N,Miyata H,Kuroda T,Ohno Y,Tanaka Y,Shibata N,Imamura Y,Kanemitsu K,Miyake T,Koizumi M,Hiasa Y,Ehime Pancreato-Cholangiology (EPOCH) Study Group Y .2021 .Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. Medicine (Baltimore), 100(43) : e27591.
Wang X,Chen D,Wen J,Mao Y,Zhu X,Fan M,Chen Y .2021 .Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: A systematic review and meta-analysis. Ann. Transl. Med, 9(18) : 1430.
Wang ZL,Guo YJ,Zhu YY,Chen L,Wu T,Liu DH,Huang BS,Du HZ .2021 .Active fractions of Camellia nitidissima inhibit non-small cell lung cancer via suppressing epidermal growth factor receptor]. Zhongguo Zhong Yao Za Zhi. , 46(20) : 5362-5371.
Zhao ZR,Yang CP,Chen S,Yu H,Lin YB,Lin YB,Lin YB,Qi H,Jin JT,Lian SS,Wang YZ,You JQ,Zhai WY,Long H WY .2021 .Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer. Oncoimmunology, 10(1) : 1996000.
Zhu Y,Shen L,Zhou Y .2021 .Nano-particulated erlotinib compound system in alleviation of lung cancer. J. Biomed. Nanotechnol., 17(10) : 1984-1992.